J. Matthew Singleton, Director: Viking Therapeutics VKTX Sell · Filed 24/08/19

Trade details

Type: Insider sale
Amount: $278,926.74
Shares · price: 4,509 sh · $61.86 a share
Held after: 15,444 sh
Stock: Viking Therapeutics VKTX
Person: J. Matthew SingletonDirector
Trade date: 24/08/19
Filed: 24/08/19
Days to filing: 0 days

Sold 22.6% of holdings

Share of holding sold: 22.6%

Viking Therapeutics trades, last 26 weeks

What else happened in Viking Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/20~24/09/18

J. Matthew Singleton's recent trades

J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$1.3M
16,000 sh
$1.3M
Filed 24/10/25
Traded 24/10/25
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$715.9K
10,300 sh
$715.9K
Filed 24/09/20
Traded 24/09/20
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$397.4K
5,700 sh
$397.4K
Filed 24/08/22
Traded 24/08/21
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$186.3K
3,047 sh
$186.3K
Filed 24/08/19
Traded 24/08/19
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$153.1K
2,388 sh
$153.1K
Filed 24/08/19
Traded 24/08/19